Sanuwave Health Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
55
- Stock Symbol
-
SNWV
- Investments
-
6
- Share Price
-
$1.80
- (As of Friday Closing)
Sanuwave Health General Information
Description
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
Contact Information
Website
www.sanuwave.comCorporate Office
- 9600 West 76th Street
- Eden Prairie, MN 55344
- United States
Corporate Office
- 9600 West 76th Street
- Eden Prairie, MN 55344
- United States
Sanuwave Health Timeline
Sanuwave Health Stock Performance
As of 13-Nov-2026, Sanuwave Health’s stock price is $1.80. Its current market cap is $15.7M with 8.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.80 | $1.58 | $1.55 - $35.29 | $15.7M | 8.6M | 80.3K | $0.49 |
Sanuwave Health Financials Summary
As of 30-Sep-2026, Sanuwave Health has a trailing 12-month revenue of $41.3M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 51,847 | 270,762 | 225,843 | 50,157 |
| Revenue | 41,331 | 44,051 | 32,634 | 20,398 |
| EBITDA | 7,850 | 19,428 | (18,132) | (9,152) |
| Net Income | 4,155 | 11,813 | (33,083) | (25,807) |
| Total Assets | 32,521 | 37,343 | 30,119 | 22,416 |
| Total Debt | 19,607 | 22,971 | 25,797 | 30,454 |
Sanuwave Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sanuwave Health Comparisons
Industry
Financing
Details
Sanuwave Health Competitors (7)
One of Sanuwave Health’s 7 competitors is Dornier MedTech, a Corporation company based in Weßling, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dornier MedTech | Corporation | Weßling, Germany | ||||
| ENvue | Corporation | Arlington Heights, IL | ||||
| Focal One | Formerly PE-Backed | Austin, TX | ||||
| Avita Medical | Corporation | Valencia, CA | ||||
| Arobella Medical | Corporation | Minnetonka, MN |
Sanuwave Health Patents
Sanuwave Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250157616-A1 | Combination medical treatments with energy systems | Pending | 08-Sep-2023 | ||
| WO-2025054601-A1 | Combination medical treatments with energy systems | Inactive | 08-Sep-2023 | ||
| US-20250058097-A1 | Pressure wave syringe device | Pending | 21-Jul-2020 | ||
| US-20220023607-A1 | Pressure waves for vaccines, genetic modification and medical treatments | Inactive | 21-Jul-2020 | ||
| WO-2022020354-A1 | Pressure waves for vaccines, genetic modification and medical treatments | Inactive | 21-Jul-2020 | A61M37/0092 |
Sanuwave Health Signals
Sanuwave Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sanuwave Health Investments & Acquisitions (6)
Sanuwave Health’s most recent deal was a Joint Venture with Joint Venture (SANUWAVE Health / MEDSTENT). The deal was made on 14-Oct-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (SANUWAVE Health / MEDSTENT) | 14-Oct-2020 | Joint Venture | Distributors (Healthcare) | ||
| Celularity (UltraMIST) | 10-Aug-2020 | Corporate Asset Purchase | Buildings and Property | ||
| dermaPACE | 07-Nov-2019 | Joint Venture | Therapeutic Devices | ||
| Advance Medical Technology (FKS/Sanuwave Health) | 26-Jun-2018 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| Medical Training Services (Sanuwave Health / Tarbaca Lightning) | 26-Jun-2018 | Joint Venture | Education and Training Services (B2B) |
Sanuwave Health ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
35.18 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Sanuwave Health FAQs
-
When was Sanuwave Health founded?
Sanuwave Health was founded in 2004.
-
Where is Sanuwave Health headquartered?
Sanuwave Health is headquartered in Eden Prairie, MN.
-
What is the size of Sanuwave Health?
Sanuwave Health has 55 total employees.
-
What industry is Sanuwave Health in?
Sanuwave Health’s primary industry is Other Devices and Supplies.
-
Is Sanuwave Health a private or public company?
Sanuwave Health is a Public company.
-
What is Sanuwave Health’s stock symbol?
The ticker symbol for Sanuwave Health is SNWV.
-
What is the current stock price of Sanuwave Health?
As of 13-Nov-2026 the stock price of Sanuwave Health is $1.80.
-
What is the current market cap of Sanuwave Health?
The current market capitalization of Sanuwave Health is $15.7M.
-
What is Sanuwave Health’s current revenue?
The trailing twelve month revenue for Sanuwave Health is $41.3M.
-
Who are Sanuwave Health’s competitors?
Dornier MedTech, ENvue, Focal One, Avita Medical, and Arobella Medical are some of the 7 competitors of Sanuwave Health.
-
What is Sanuwave Health’s annual earnings per share (EPS)?
Sanuwave Health’s EPS for 12 months was $0.49.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process